Article
Pharmacological correction of gating defects in the voltage-gated Ca(v)2.1 Ca²⁺ channel due to a familial hemiplegic migraine mutation.
Neuron - 8 Jan 2014
Inagaki Akira, Frank C Andrew, Usachev Yuriy M, Benveniste Morris, Lee Amy
Abstract excerpt
Voltage-gated ion channels exhibit complex properties, which can be targeted in pharmacological therapies for disease. Here, we report that the pro-oxidant, tert-butyl dihydroquinone (BHQ), modulates Ca(v)2.1 Ca²⁺ channels in ways that oppose defects in channel gating and synaptic transmission resulting from a familial hemiplegic migraine mutation (S218L). BHQ slows deactivation, inhibits voltage-dependent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
